Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study

Autor:	Santin M, Morandeira-Rego F, Alcaide F, Rabuñal R, Anibarro L, Agüero-Balbín R, Casas X, Pérez-Escolano E, Navarro MD, Sánchez F, Coira-Nieto A, Trigo-Daporta M, Martinez-Meñaca A, Gonzalez-Cuevas MA, López-Prieto MD, Domínguez-Castellano Á, Jové N
Rok vydání:	2016
Předmět:	bacterial infections and mycoses Active tuberculosis Interferon-? Interleukin-2 Latent tuberculosis infection QuantiFERON
Zdroj:	CLINICAL MICROBIOLOGY AND INFECTION r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu Fundació Sant Joan de Déu
ISSN:	1198-743X
Popis:	Previous reports have identified interleukin-2 (IL-2), quantified in the supernatants of QuantiFERON(®)-TB Gold In-tube (QFT) after 72 h of incubation, as a potential biomarker for distinguishing between latent and active tuberculosis (TB). However, its validity has not been tested in an appropriate clinical cohort.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::56b473b45388832a9c59ba3370c56d50 http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10134 Zobrazit plný text záznamu